GADSDEN REPORT
Don't Tread On The Truth
Politics & Policy

Pro-life CEO predicts Trump FDA nominee could bring renewed scrutiny to abortion drug risks

Trump's FDA nominee Heidi Overton could bring renewed scrutiny to mifepristone, says Americans United for Life CEO who calls her a "pro-life" pick. Read more at FOX ›
Read the full story at
FOX
Open the original

The Gadsden Report aggregates and summarises headlines. The reporting above belongs to FOX, and the link opens their page. This page exists so readers can find, share, and discuss the story here.

Discussion — 0 comments

No comments yet. Be the first.